118 related articles for article (PubMed ID: 8668343)
21. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding.
McEwan IJ; Dahlman-Wright K; Ford J; Wright AP
Biochemistry; 1996 Jul; 35(29):9584-93. PubMed ID: 8755740
[TBL] [Abstract][Full Text] [Related]
22. Function of the c-Myc oncogenic transcription factor.
Dang CV; Resar LM; Emison E; Kim S; Li Q; Prescott JE; Wonsey D; Zeller K
Exp Cell Res; 1999 Nov; 253(1):63-77. PubMed ID: 10579912
[TBL] [Abstract][Full Text] [Related]
23. The myc gene family proteins and their role in transformation and differentiation.
Ingvarsson S
Semin Cancer Biol; 1990 Dec; 1(6):359-69. PubMed ID: 2103508
[TBL] [Abstract][Full Text] [Related]
24. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
25. Interferon-induced upregulation and cytoplasmic localization of Myc-interacting protein Nmi.
Lebrun SJ; Shpall RL; Naumovski L
J Interferon Cytokine Res; 1998 Sep; 18(9):767-71. PubMed ID: 9781816
[TBL] [Abstract][Full Text] [Related]
26. The high-mobility group transcription factor Sox10 interacts with the N-myc-interacting protein Nmi.
Schlierf B; Lang S; Kosian T; Werner T; Wegner M
J Mol Biol; 2005 Nov; 353(5):1033-42. PubMed ID: 16214168
[TBL] [Abstract][Full Text] [Related]
27. Translocations involving c-myc and c-myc function.
Boxer LM; Dang CV
Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
[TBL] [Abstract][Full Text] [Related]
28. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a new melanocyte-specific gene (QNR-71) expressed in v-myc-transformed quail neuroretina.
Turque N; Denhez F; Martin P; Planque N; Bailly M; Bègue A; Stéhelin D; Saule S
EMBO J; 1996 Jul; 15(13):3338-50. PubMed ID: 8670835
[TBL] [Abstract][Full Text] [Related]
30. Human ESP1/CRP2, a member of the LIM domain protein family: characterization of the cDNA and assignment of the gene locus to chromosome 14q32.3.
Karim MA; Ohta K; Egashira M; Jinno Y; Niikawa N; Matsuda I; Indo Y
Genomics; 1996 Jan; 31(2):167-76. PubMed ID: 8824798
[TBL] [Abstract][Full Text] [Related]
31. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
[TBL] [Abstract][Full Text] [Related]
32. Gene structure and expression of the targeting subunit, RGL, of the muscle-specific glycogen-associated type 1 protein phosphatase, PP1G.
Lannér C; Suzuki Y; Bi C; Zhang H; Cooper LD; Bowker-Kinley MM; DePaoli-Roach AA
Arch Biochem Biophys; 2001 Apr; 388(1):135-45. PubMed ID: 11361130
[TBL] [Abstract][Full Text] [Related]
33. LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family.
Petit MM; Mols R; Schoenmakers EF; Mandahl N; Van de Ven WJ
Genomics; 1996 Aug; 36(1):118-29. PubMed ID: 8812423
[TBL] [Abstract][Full Text] [Related]
34. Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
D'Agnano I; Valentini A; Gatti G; Chersi A; Felsani A
J Cell Physiol; 2007 Jan; 210(1):72-80. PubMed ID: 16998799
[TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc.
Armstrong BC; Krystal GW
Cell Growth Differ; 1992 Jun; 3(6):385-90. PubMed ID: 1419902
[TBL] [Abstract][Full Text] [Related]
36. Human N-myc is closely related in organization and nucleotide sequence to c-myc.
Kohl NE; Legouy E; DePinho RA; Nisen PD; Smith RK; Gee CE; Alt FW
Nature; 1986 Jan 2-8; 319(6048):73-7. PubMed ID: 3510398
[TBL] [Abstract][Full Text] [Related]
37. Interferon-inducible Myc/STAT-interacting protein Nmi associates with IFP 35 into a high molecular mass complex and inhibits proteasome-mediated degradation of IFP 35.
Chen J; Shpall RL; Meyerdierks A; Hagemeier M; Böttger EC; Naumovski L
J Biol Chem; 2000 Nov; 275(46):36278-84. PubMed ID: 10950963
[TBL] [Abstract][Full Text] [Related]
38. A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer.
Li H; Lee TH; Avraham H
J Biol Chem; 2002 Jun; 277(23):20965-73. PubMed ID: 11916966
[TBL] [Abstract][Full Text] [Related]
39. Intracellular redistribution of interferon-inducible proteins Nmi and IFP 35 in apoptotic cells.
Chen J; Naumovski L
J Interferon Cytokine Res; 2002 Feb; 22(2):237-43. PubMed ID: 11911807
[TBL] [Abstract][Full Text] [Related]
40. N-myc oncogene expression in porcine renal development and oncogenesis.
Bendit I; Rich MA; Moldwin R; Waber P; Steinberg BM; Nisen PD
Pediatr Res; 1991 Mar; 29(3):268-71. PubMed ID: 2034474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
